Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Share-based Compensation (2020 - 2025)

Definitive Healthcare (DH) has disclosed Share-based Compensation for 6 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 10.81% year-over-year to $8.2 million, compared with a TTM value of $29.1 million through Dec 2025, down 23.48%, and an annual FY2025 reading of $29.1 million, down 23.48% over the prior year.
  • Share-based Compensation was $8.2 million for Q4 2025 at Definitive Healthcare, up from $6.7 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $15.6 million in Q1 2024 and bottomed at $406000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $8.1 million, with a median of $7.8 million recorded in 2024.
  • The sharpest move saw Share-based Compensation soared 1592.61% in 2022, then plummeted 53.03% in 2025.
  • Year by year, Share-based Compensation stood at $5.6 million in 2021, then soared by 103.31% to $11.4 million in 2022, then grew by 16.02% to $13.3 million in 2023, then plummeted by 44.43% to $7.4 million in 2024, then rose by 10.81% to $8.2 million in 2025.
  • Business Quant data shows Share-based Compensation for DH at $8.2 million in Q4 2025, $6.7 million in Q3 2025, and $7.0 million in Q2 2025.